Serophene
Serophene
- In our pharmacy you can buy serophene without a prescription, with delivery across the United Kingdom and discreet packaging; note that clomiphene is classed as prescription-only in many countries and its use is normally recommended under medical supervision.
- Serophene (clomiphene citrate) is used to induce ovulation in anovulatory or oligo‑ovulatory infertility (including PCOS); it is a selective oestrogen receptor modulator that blocks oestrogen feedback at the hypothalamus, increasing GnRH and subsequently FSH/LH to stimulate follicular development and ovulation.
- The usual dose is 50 mg orally once daily for 5 days (typically starting on cycle day 2–5); if ovulation does not occur the dose may be increased to 100 mg daily for 5 days in subsequent cycles, with most guidelines advising treatment for up to 3–5 cycles.
- Administered orally as a 50 mg tablet.
- Effects begin within a few days of treatment; ovulation commonly occurs about 5–10 days after the course is completed.
- The pharmacological effect persists for the menstrual cycle following treatment (clomiphene has a long elimination half‑life measured in days, with ovulation‑inducing effects lasting through that cycle).
- Avoid excessive alcohol while trying to conceive and while taking fertility treatments; alcohol can worsen side effects and may negatively affect fertility—best to limit or abstain.
- The most common side effect is hot flashes; other frequent effects include abdominal discomfort, bloating, nausea, breast tenderness, headache and transient visual disturbances.
- Would you like to try serophene without a prescription?
Basic Serophene Information
- INN (International Nonproprietary Name): Clomiphene citrate.
- Brand Names Available In United Kingdom: not specified.
- ATC Code: G03GB02 – Clomifene.
- Forms & Dosages: Tablet, 50 mg (brands: Serophene, Clomid).
- Manufacturers In United Kingdom: not specified.
- Registration Status In United Kingdom: not specified.
- OTC / Rx Classification: Prescription only (Rx).
Latest Research Highlights (UK And EU)
Is clomifene still a go-to for ovulation induction in recent UK and EU studies?
Recent systematic reviews and multicentre cohort analyses from 2022–2025 revisited clomifene citrate versus aromatase inhibitors and gonadotrophins.
Those papers report per‑cycle ovulation rates for clomifene in the mid‑range, commonly around 50–80% depending on patient selection and monitoring intensity.
Live‑birth advantages compared with letrozole were inconsistent in PCOS cohorts, so several European fertility centres now favour letrozole as first‑line for PCOS while keeping clomifene for other anovulatory causes.
Post‑marketing safety surveillance summaries (MHRA Yellow Card reports) continue to list visual disturbances, hot flushes and ovarian enlargement among the leading adverse event reports for clomifene.
The International Nonproprietary Name is clomiphene citrate and the ATC code is G03GB02.
| Outcome | Typical Range Reported (2022–2025) | Notes |
|---|---|---|
| Per‑Cycle Ovulation Rate | Approximately 50–80% | Varies with monitoring and population |
| Clinical Pregnancy Rate | Variable; cohort dependent | Depends on BMI, duration of infertility |
| Live Birth Rate | Less consistent vs letrozole in PCOS | Many EU centres prefer letrozole for PCOS |
Data Highlight: The most commonly reported adverse events in UK/EU surveillance are visual disturbance, hot flushes and ovarian enlargement.
Clinical Effectiveness In The UK
What can patients expect from clomifene in NHS and private clinic practice?
Audits and NHS practice data show clomifene remains effective when used with appropriate monitoring such as ultrasound and mid‑luteal progesterone measurement.
Success with clomifene depends on factors including BMI, duration of infertility and the underlying diagnosis.
Patient‑reported outcomes on UK forums and clinic surveys highlight faster cycles to ovulation for many, balanced against mixed satisfaction because of side effects such as mood changes and visual blurring.
Fertility outcomes are optimised when clomifene is combined with lifestyle measures for PCOS and close follow‑up to minimise ovarian hyperstimulation risk.
- NHS Outcome Measures: Ovulation rate, clinical pregnancy rate, live birth rate.
| Action | Typical Cycle Days |
|---|---|
| Start clomifene | Cycle Days 2–5 |
| Transvaginal ultrasound follow‑up | Mid follicular and pre‑ovulatory days (as clinic protocol) |
| Mid‑luteal progesterone | Seven days after presumed ovulation |
Indications And Expanded Uses
Who is clomifene licensed for, and when is it used off‑label?
MHRA‑aligned indications in the UK and EU cover ovulation induction for anovulatory or oligo‑ovulatory infertility, including many cases of PCOS where appropriate.
Clomifene is also used as part of stepwise care for some cases of unexplained infertility.
Off‑label uses in private clinics can include minimal stimulation protocols or timed intercourse support, provided there is a documented rationale and informed consent.
Absolute contraindications include pregnancy, liver disease, unexplained uterine bleeding and hormone‑dependent tumours.
- Licensed: Ovulation induction for anovulatory or oligo‑ovulatory infertility.
- Off‑Label: Minimal stimulation protocols, timed intercourse support (with consent).
- Contraindicated: Pregnancy, liver disease, unexplained uterine bleeding, hormone‑dependent tumours.
| MHRA Use | Common Private Practice Application |
|---|---|
| Ovulation induction (anovulatory infertility) | Minimal stimulation or timed intercourse support with consent |
| Stepwise care in unexplained infertility | Used according to local trust formularies |
Composition And Brand Landscape
Which brands and manufacturers supply clomifene around the world and in the UK market?
The active ingredient is clomiphene citrate (INN) and the standard formulation is a 50 mg tablet.
Common global brands include Serophene and Clomid, with regional generics such as Fertomid and Clostilbegyt also widely available.
Major manufacturers named in public product information are Sanofi‑Aventis, Teva, Merck Serono and Zentiva, with additional suppliers from India including Cipla and Sun Pharma.
In the UK, branded Serophene may be less common than generic clomifene supplied by major wholesalers, so pharmacists should check batch information and excipient lists for allergy concerns.
| Brand | Formulation | Common Pack Sizes |
|---|---|---|
| Serophene / Clomid | 50 mg tablet | Blister strips, bottles |
| Fertomid / Clostilbegyt | 50 mg tablet | Various pack sizes |
- Major Manufacturers: Sanofi‑Aventis, Teva, Merck Serono, Zentiva, Cipla, Sun Pharma.
Contraindications And Special Precautions
When must clomifene be avoided and when should clinicians take extra care?
Absolute contraindications listed in product information include pregnancy, hepatic disease and unexplained vaginal bleeding.
Relative precautions apply to PCOS due to the risk of multiple pregnancy or ovarian hyperstimulation, and to those with pre‑existing visual disturbances.
Thyroid and adrenal dysfunction should be assessed and managed before starting treatment.
Patients should be advised not to drive if visual blurring occurs and to stop treatment immediately if visual symptoms develop.
- Absolute Contraindications: Pregnancy, liver disease, unexplained uterine bleeding, hormone‑dependent tumours, hypersensitivity to excipients.
- Relative Precautions: PCOS (OHSS risk), pre‑existing visual disturbance, thyroid/adrenal dysfunction, significant obesity.
Data Highlight: MHRA Yellow Card reports most commonly list visual disturbance, ovarian enlargement and mood change.
Dosage Guidelines
How is clomifene usually dosed and what is the escalation strategy?
The standard starting regimen used across NHS and private UK practice is 50 mg orally once daily for five days, typically starting on cycle days 2–5.
If ovulation does not occur, many clinicians increase the dose to 100 mg daily for five days in subsequent cycles.
Most centres advise review after three treatment cycles, although some guidance allows up to five cycles before re‑evaluation.
- Start 50 mg once daily for five days, usually cycle days 2–5.
- If no ovulation, consider 100 mg once daily for five days in the next cycle.
- Limit treatment to three cycles before formal re‑assessment; some guidance allows five cycles.
| Regimen Step | Action / Timing |
|---|---|
| Initiation | 50 mg daily for 5 days (cycle days 2–5) |
| Escalation | 100 mg daily for 5 days if no ovulation |
| Monitoring | Ultrasound and progesterone checks as per protocol |
Interactions Overview
Which medicines and substances can affect safety or effectiveness when taken with clomifene?
Clomifene has few classic pharmacokinetic food interactions, but clinical interactions are important to consider.
Concurrent oestrogen therapy may blunt clomifene’s effect and should be reviewed before starting.
Antidepressant agents and other psychoactive medicines require careful consideration because of overlapping mood and visual adverse effects.
Alcohol and recreational substances can exacerbate neuropsychiatric side effects and should be limited.
- Major Interaction Classes: Hormonal agents (oestrogens), psychoactive drugs (antidepressants, antipsychotics), medicines with hepatic burden.
- Contraindicated: No specific pharmacokinetic absolute contraindication listed, but concurrent pregnancy or hormone‑dependent tumours preclude use.
- Caution: Use with antidepressants or other mood‑altering medicines; monitor for mood change.
- Monitor: Hepatically metabolised co‑medicines due to liver metabolism of clomifene.
Cultural Perceptions And Patient Habits
What do UK patients say about taking clomifene and where do they seek advice?
UK patient fora and clinic feedback show a strong cultural reliance on pharmacist counselling and NHS sources for fertility questions.
Patients frequently seek peer advice about side effects such as mood swings and vision changes, and about brand differences and cost.
Many prefer in‑person counselling at high‑street pharmacies such as Boots or LloydsPharmacy before starting treatment.
Remote follow‑up via electronic prescriptions and NHS patient portals is common, while face‑to‑face ultrasound monitoring remains expected for reassurance.
- Insight 1: Some patients choose private clinics for perceived speed; others prefer NHS continuity because of trust in local services.
- Insight 2: Fertility stigma varies; confidentiality and discreet packaging are commonly requested.
Pharmacist Counselling Checklist: discuss dosing schedule, expected side effects, need for ultrasound monitoring and steps for reporting adverse events.
Availability And Pricing Patterns
How are serophene and generic clomifene typically accessed and what does it cost in the UK?
Clomifene is a prescription‑only medicine in official product information, usually available via NHS prescription or private clinic prescription and supplied through community pharmacies and licensed online pharmacies.
In England there are per‑item prescription charges unless a patient is exempt, while Scotland, Wales and Northern Ireland offer free NHS prescriptions and this affects purchasing patterns.
Generic clomifene is typically cheaper than branded Serophene, and private clinic fees vary by region.
In our online pharmacy, serophene is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.
| Access Route | Typical Cost / Note |
|---|---|
| NHS Prescription | Subject to regional prescription charging rules |
| Private Clinic Prescription | May include clinic supply charges |
| Licensed Online Pharmacy | Price varies; generic options tend to be cheaper |
- Common Supply Routes: Local pharmacy chains (Boots, LloydsPharmacy, Superdrug), clinic dispensaries, licensed online pharmacies.
- Electronic prescribing options: NHS e‑prescriptions and private e‑scripts for clinic patients.
Comparable Medicines And Preferences
How does clomifene compare with letrozole and gonadotrophins in UK practice?
Letrozole, an aromatase inhibitor, is often preferred for PCOS in the UK because several analyses suggest higher live‑birth rates in that subgroup.
Gonadotrophins are used as second‑line agents for induction or as part of IVF protocols when oral agents fail.
Metformin remains an adjunct in insulin‑resistant PCOS, often used alongside ovulation induction strategies.
- Pros Of Clomifene: Oral dosing, widely available, cost‑effective.
- Cons Of Clomifene: Anti‑oestrogenic effects on endometrium, potential visual side effects, variable live‑birth data in PCOS.
| Medicine | Ease Of Use | Cost | Typical Efficacy | Side‑Effect Profile |
|---|---|---|---|---|
| Clomifene | Easy (oral) | Low | Good for many anovulatory patients | Hot flushes, visual effects |
| Letrozole | Easy (oral) | Moderate | Often better live‑births in PCOS | Fatigue, headache |
| Gonadotrophins | Injectable | High | High ovulation rates when monitored | OHSS risk, multiple pregnancy risk |
FAQ Section (NHS Patient Questions)
Will Serophene make me ovulate in the first cycle?
Many patients ovulate within one or two cycles, but response varies by diagnosis and BMI.
Is it safe to drive on clomifene?
Avoid driving if visual blurring or dizziness occurs and report symptoms promptly.
Can I drink alcohol while taking clomifene?
Moderate alcohol is not strictly contraindicated, but limiting intake reduces the chance of mood‑related adverse effects.
How long will the NHS prescribe it?
Clinicians often review after three cycles; local pathways vary and some allow up to five cycles before further investigation.
| Symptom | Action |
|---|---|
| Visual change | Stop treatment and seek urgent review |
| Severe abdominal pain | Seek emergency assessment |
| Hot flushes or mood change | Report to prescriber; consider review of dose |
Guidelines For Proper Use And Counselling
What should pharmacists tell patients before they start serophene?
Counselling should include the dosing schedule of 50 mg daily for five days, usually cycle days 2–5, and the need for a baseline pregnancy test before initiation.
Advise patients about the expected timeline for ovulation and the need for ultrasound monitoring when indicated.
Explain red‑flag symptoms that require immediate action, such as visual changes or severe abdominal pain.
Ensure informed consent is documented for any off‑label use and arrange ultrasound monitoring to reduce OHSS risk.
- Check a pregnancy test prior to starting.
- Provide a written dosing schedule and monitoring plan.
- Advise to report visual disturbance or severe pain immediately.
| Cycle Day | Action |
|---|---|
| Day 1–5 | Start/complete 5‑day dosing (50 mg unless adjusted) |
| Mid Follicular | Ultrasound monitoring if prescribed |
| Mid‑Luteal | Progesterone check to confirm ovulation |
Report adverse reactions via the MHRA Yellow Card scheme and guide patients to NHS portals for follow‑up.
Delivery Across United Kingdom
| City | Region | Delivery Time |
|---|---|---|
| London | England | 5–7 days |
| Birmingham | England | 5–7 days |
| Manchester | England | 5–7 days |
| Glasgow | Scotland | 5–7 days |
| Leeds | England | 5–7 days |
| Edinburgh | Scotland | 5–7 days |
| Bristol | England | 5–7 days |
| Liverpool | England | 5–9 days |
| Newcastle Upon Tyne | England | 5–9 days |
| Nottingham | England | 5–9 days |
| Cardiff | Wales | 5–9 days |
| Belfast | Northern Ireland | 5–9 days |
| Southampton | England | 5–9 days |